Crystal Structures of Candida albicans Phosphodiesterase 2 and Implications for Its Biological Functions

Biochemistry
Ting YaoHengming Ke

Abstract

The cAMP signaling system plays important roles in the physiological processes of pathogen yeast Candida albicans, but its functional mechanism has not been well illustrated. Here, we report the enzymatic characterization and crystal structures of C. albicans phosphodiesterase 2 (caPDE2) in the unliganded and 3-isobutyl-1-methylxanthine-complexed forms. caPDE2 is a monomer in liquid and crystal states and specifically hydrolyzes cAMP with a KM of 35 nM. It does not effectively hydrolyze cGMP as shown by the 1.32 × 105-fold specificity of cAMP/cGMP. The crystal structure of caPDE2 shows significant differences from those of human PDEs. First, the N-terminal fragment of caPDE2 (residues 1-201) tightly associates with the catalytic domain to form a rigid molecular entity, implying its stable molecular conformation for C. albicans to resist environmental stresses. Second, the M-loop, a critical fragment for binding of the substrate and inhibitors to human PDEs, is not a part of the caPDE2 active site. This feature of caPDE2 may provide a structural basis for the design of selective inhibitors for the treatment of yeast infection.

References

Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P SassM Wigler
Sep 5, 2002·Nature Reviews. Drug Discovery·David P Rotella
Dec 31, 2003·Methods in Enzymology·Martyn D WinnMiroslav Z Papiz
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Qing HuaiHengming Ke
Dec 4, 2004·Structure·Graeme L CardKam Y J Zhang
Jul 5, 2005·The Journal of Biological Chemistry·Huanchen WangHengming Ke
Nov 1, 2005·Current Opinion in Infectious Diseases·Carlos I Bustamante
Nov 18, 2005·The New England Journal of Medicine·Nazzareno GalièUNKNOWN Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema
Feb 20, 2007·Current Topics in Medicinal Chemistry·Hengming Ke, Huanchen Wang
Jun 22, 2007·Journal of Molecular Biology·Huanchen WangHengming Ke
Dec 13, 2007·Nature Reviews. Molecular Cell Biology·Gyorgy Hutvagner, Martin J Simard
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Jun 9, 2011·British Journal of Clinical Pharmacology·Paolo GreseleEmanuela Falcinelli
Apr 2, 2014·Nature Reviews. Drug Discovery·Donald H MauriceVincent C Manganiello
Mar 20, 2015·Current Gastroenterology Reports·Askin Erdogan, Satish S C Rao
May 1, 2016·Nucleic Acids Research·Liisa Holm, Laura M Laakso
Oct 13, 2016·Annual Review of Pharmacology and Toxicology·Kristen Kokkonen, David A Kass
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor
Jan 1, 1997·Methods in Enzymology·Jorge Navaza, Pedro Saludjian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.